Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities

L Natoli, L Mahler, L Kaldor, J Ward, M Shephard, D Anderson, R Guy

    Research output: Contribution to conferencePaperpeer-review

    Abstract

    Background: The GeneXpert- is a new molecular point-of-care (POC) test device for diagnosing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). It recently received regulatory approval in the US, Europe and Australia, and is being used routinely in remote Aboriginal health services in Australia as part of the TTANGO (Test, Treat, ANd GO) Trial. Previously, most CT/NG POC tests have suff ered from being inaccurate and complex.
    Original languageEnglish
    Pages15
    Number of pages1
    Publication statusPublished - 2014
    Event2014 Australasian Sexual Health Conference: Condoms & Beyond, Completing the Sexual Health Picture -
    Duration: 9 Oct 2014 → …

    Conference

    Conference2014 Australasian Sexual Health Conference
    Period9/10/14 → …

    Keywords

    • Chlamydia
    • Gonorrhoea
    • Remote Communities

    Fingerprint Dive into the research topics of 'Benefits and barriers to integration of chlamydia and gonorrhoea point-of-care testing into remote communities'. Together they form a unique fingerprint.

    Cite this